Cellular reprogramming to enable the consistent and scalable manufacturing of human cells for therapeutic applications

Time: To be announced
To be announced
Dr Alex Davenport


Having access to a reliable and consistent source of human cells is a potential game changer for cell therapies. In this talk, we introduce opti-ox, bit.bio's technology that enables fast, consistent and scalable manufacturing of human cells. Based on the principle that transcription factors (TFs) control cell identity, TF-driven cellular reprogramming offers a disruptive strategy for cell differentiation. By applying a cellular reprogramming approach, the typical restrictions of standard hiPSC differentiation systems - time, complexity, and lack of consistency and purity - have been largely overcome.
To view the video assoicated with this lecture click here

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021